News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Breakthrough in cancer cachexia with Ponsegromab treatment
Photo taken from John Groarke/LinkedIn
Sep 23, 2024, 13:34

Breakthrough in cancer cachexia with Ponsegromab treatment

Hagen Kennecke, Chief health officer of the OHSU Knight-Legacy Health Cancer Collaborative, shared a post by NEJM, on X:

“Possible breakthrough in cancer cachexia with Ponsegromab, anti-GDF 15.

Significant weight gain, especially in patients with colorectal cancer.”

Quoting NEJM’s post:

“Ponsegromab for the Treatment of Cancer Cachexia.

Authors: John D. Groarke, Jeffrey Crawford,  Susie M. Collins,  Shannon Lubaczewski,Eric J. Roeland, Tateaki Naito,  Andrew E. Hendifar,Marie Fallon, Koichi Takayama, Timothy Asmis, Richard F. Dunne,Isik Karahanoglu, Carrie A. Northcott, Magdalena A. Harrington, Michelle Rossulek, Ruolun Qiu , Aditi R. Saxena.“

Breakthrough in cancer cachexia with Ponsegromab treatment

Breakthrough in cancer cachexia with Ponsegromab treatment

Source: Hagen Kennecke/X and NEJM/X

 

Aditi R. Saxena Andrew E. Hendifar anti- GDF15 cachexia cancer Carrie A. Northcott colorectal cancer Eric J. Roeland Hagen Kennecke Isik Karahanoglu Jeffrey Crawford John D. Groarke Koichi Takayama Magdalena A. Harrington Marie Fallon Michelle Rossulek NEJM OncoDaily Oncology Ponsegromab Richard F. Dunne Ruolun Qiu Shannon Lubaczewski Susie M. Collins Tateaki Naito Timothy Asmis
Special Coverage
Blog
Nov 7, 2024, 00:25
Arif Kamal: The beauty of transforming a person's story into words in serious illness care
Blog
Nov 7, 2024, 00:22
European School of Oncology - Stronger Together: United for Lung Cancer Awareness
Blog
Nov 7, 2024, 00:18
SIOP Europe - Championing Children’s Health: Advancing Paediatric Oncology
Blog
Nov 7, 2024, 00:15
IARC - Long-Term Survival and Recurrence in Women with Non-Metastatic Breast Cancer
Blog
Nov 7, 2024, 00:11
Chandler Park's Insights on the SunRISe Program and the Potential of TAR-200 for High-Risk Bladder Cancer
Blog
Nov 7, 2024, 00:06
Ruzanna Papyan Highlights Global Accessibility of Neuroblastoma Treatments at SIOP Annual Congress
Blog
Nov 7, 2024, 00:04
Karen Knudsen: Policy change needed for patients without PCPs
Blog
Nov 7, 2024, 00:02
Hedley Lewis: For 45 years, CHOC has stood as a beacon of hope for facing the daunting journey of treatment
Blog
Nov 7, 2024, 00:01
Mara Antonoff: The MD Anderson Cancer Center and the Department of Thoracic and Cardiovascular Surgery offer a clinical research fellowship
Celebrities
Nov 6, 2024, 20:29
Shannon Miller and Ovarian Cancer: How She Went Against, How She Survived, and More
Blog
Nov 6, 2024, 18:17
Roupen Odabashian: ChatGPT vs Claude for Cancer patients
Blog
Nov 6, 2024, 18:12
Prioritizing Cancer Early Detection and Management in the Eastern Mediterranean Region - Eastern Mediterranean NCD Alliance